HELIOS-A: 9-month Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

被引：0

作者：

Adams, David ^{[1
]}

Tournev, Ivailo L. ^{[2
,3
]}

Taylor, Mark S. ^{[4
,5
]}

Coelho, Teresa ^{[6
]}

Plante-Bordeneuve, Violaine ^{[7
]}

Berk, John L. ^{[8
]}

Gonzalez-Duarte, Alejandra ^{[9
]}

Gillmore, Julian D. ^{[10
]}

Low, Soon-Chai ^{[11
]}

Sekijima, Yoshiki ^{[12
]}

Obici, Laura ^{[13
]}

Blakesley, Rick ^{[14
]}

Arum, Seth ^{[14
]}

Shilling, Rebecca ^{[14
]}

Vest, John ^{[14
]}

Polydefkis, Michael ^{[15
]}

机构：

[1] Univ Paris Saclay, CHU Bicetre, APHP, Dept Neurol,INSERM U1195, Paris, France

[2] Med Univ Sofia, Univ Hosp Aleksandrovska, Dept Neurol, Clin Nervous Dis, Sofia, Bulgaria

[3] New Bulgarian Univ, Dept Cognit Sci, Sofia, Bulgaria

[4] Univ Sydney, Westmead Hosp, Dept Clin Immunol & Allergy, Sydney, NSW, Australia

[5] Univ Sydney, Westmead Clin Sch, Sydney, NSW, Australia

[6] Hosp Santo Antonio, Ctr Hosp Porto, Porto, Portugal

[7] CHU Henri Mondor, Assistance Publ Hop Paris, Neurol Amyloid network, Creteil, France

[8] Boston Med Ctr, Boston, MA USA

[9] Inst Nacl Ciencias Medicas Nutr Salvador Zubiran, Madrid, Spain

[10] UCL, Royal Free Hosp, Natl Amyloidosis Ctr, London, England

[11] Univ Malaya, Dept Med, Div Neurol, Kuala Lumpur, Malaysia

[12] Shinshu Univ, Dept Med Neurol Rheumatol, Sch Med, Matsumoto, Nagano, Japan

[13] IRCCS Fdn Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy

[14] Alnylam Pharm, Cambridge, England

[15] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1234

引用

页数：4

共 50 条

[41] Impact of patisiran on norfolk QOL-DN in patients with hereditary transthyretin-mediated amyloidosis: results from the cardiac subpopulation in the phase 3 apollo study
Merlini, G.
Solomon, S.
Adams, D.
Coelho, T.
Damy, T.
Mauer, M.
Partisano, A. M.
Chen, J.
Karsten, V.
Vest, J.
Suhr, O. L. E.
Kristen, A.
EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 383 - 383
[42] PRIMARY RESULTS FROM APOLLO-B, A PHASE 3 STUDY OF PATISIRAN IN PATIENTS WITH TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH CARDIOMYOPATHY
Longhi, Simone
Maurer, Mathew S.
Fontana, Marianna
Berk, John L.
Gustafsson, Finn
Simoes, Marcos
Grogan, Martha
Fernandes, Fabio
Gottlieb, Robert L.
Kubanek, Milos
Poulsen, Steen
Damy, Thibaud
Diemberger, Igor
Tahara, Nobuhiro
Yu, Wen-chuhg
Tang, W. H. Wilson
Obici, Laura
Gonzalez-duarte, Alejandra
Sekijima, Yoshiki
White, Matthew T.
Yureneva, Elena
Jay, Patrick Y.
Vest, John
Gillmore, Julian D.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
[43] Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
Adams, David
Polydefkis, Michael
Gonzalez-Duarte, Alejandra
Wixner, Jonas
Kristen, Arnt, V
Schmidt, Hartmut H.
Berk, John L.
Losada Lopez, Ines Asuncion
Dispenzieri, Angela
Quan, Dianna
Conceicao, Isabel M.
Slama, Michel S.
Gillmore, Julian D.
Kyriakides, Theodoros
Ajroud-Driss, Senda
Waddington-Cruz, Marcia
Mezei, Michelle M.
Plante-Bordeneuve, Violaine
Attarian, Shahram
Mauricio, Elizabeth
Brannagan, Thomas H., III
Ueda, Mitsuharu
Aldinc, Emre
Wang, Jing Jing
White, Matthew T.
Vest, John
Berber, Erhan
Sweetser, Marianne T.
Coelho, Teresa
LANCET NEUROLOGY, 2021, 20 (01): : 49 - 59
[44] Impact of prior TTR stabilizer use in patients with hereditary Transthyretin-Mediated Amyloidosis in the APOLLO phase-3 study of Patisiran
Coelho, T.
Adams, D.
Gonzalez-Duarte, A.
O'Riordan, W.
Yang, C-C.
Yamashita, T.
Kristen, A.
Tournev, I.
Schmidt, H.
Berk, J.
Lin, K-P.
Gandhi, P.
Sweetser, M.
Chen, J.
Goyal, S.
Gollob, J.
Suhr, O.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 17 - 18
[45] Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
Obici, Laura
Berk, John L.
Gonzalez-Duarte, Alejandra
Coelho, Teresa
Gillmore, Julian
Schmidt, Hartmut H. -J.
Schilling, Matthias
Yamashita, Taro
Labeyrie, Celine
Brannagan, Thomas H., III
Ajroud-Driss, Senda
Gorevic, Peter
Kristen, Arnt V.
Franklin, Jaclyn
Chen, Jihong
Sweetser, Marianne T.
Wang, Jing Jing
Adams, David
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2020, 27 (03): : 153 - 162
[46] NT-proBNP Levels in Patients with Hereditary Transthyretin-mediated Amyloidosis Treated in the Phase 3 APOLLO Study Based on Diuretic Use
Grogan, Martha
Adams, David
Coelho, Teresa
Kristen, Arnt
Dispenzieri, Angela
Solomon, Scott
Gollob, Jared
Goyal, Sunita
Partisano, Angela M.
Chen, Jihong
Vest, John
Suhr, Ole B.
JOURNAL OF CARDIAC FAILURE, 2018, 24 (08) : S59 - S59
[47] Burden of Hereditary Transthyretin Amyloidosis With Polyneuropathy in Patients Enrolled in the Phase 3 Study NEURO-TTR
Berk, John
Wang, Annabel K.
Coelho, Teresa
Cruz, Marcia Waddington
Polydefkis, Michael J.
Dyck, Peter J.
Scheinberg, Morton
Plante-Bordeneuve, Violaine
Barroso, Fabio
Adams, David
Brannagan, Thomas
Whelan, Carol
Drachman, Brian M.
Heitner, Stephen B.
Conceicao, Isabel
Schmidt, Hartmut
Vita, Giuseppe
Campistol, Josep M.
Gamez, Josep
Gane, Edward
Gorevic, Peter
Bulle Oliveira, Acary Souza
Monia, Brett P.
Hughes, Stephen G.
Kwoh, Jesse
McEvoy, Bradley W.
Baker, Brenda F.
Ackermann, Elizabeth J.
Guthrie, Spencer
Kessler, Asia Sikora
Gertz, Morie
Benson, Merrill D.
Merlini, Giampaolo
NEUROLOGY, 2018, 90
[48] Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study
Lin, Kon-Ping
Yang, Chih-Chao
Lee, Yi-Chung
Lee, Ming-Jen
Vest, John
Sweetser, Marianne T.
White, Matthew T.
Badri, Prajakta
Hsieh, Sung-Tsang
Chao, Chi-Chao
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (09) : 975 - 984
[49] Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR) (vol 15, pg 613, 2020)
Judge, Daniel P.
Kristen, Arnt V.
Grogan, Martha
Maurer, Mathew S.
Falk, Rodney H.
Hanna, Mazen
Gillmore, Julian
Garg, Pushkal
Vaishnaw, Akshay K.
Harrop, Jamie
Powell, Christine
Karsten, Verena
Zhang, Xiaoping
Sweetser, Marianne T.
Vest, John
Hawkins, Philip N.
CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (06) : 889 - 889
[50] Patisiran, an RNAi therapeutic for patients with hereditary transthyretin-mediated amyloidosis: Sub-analysis in Japanese patients from the APOLLO study
Yamashita, Taro
Ueda, Mitsuharu
Koike, Haruki
Sekijima, Yoshiki
Yoshinaga, Tsuneaki
Kodaira, Minori
Katsuno, Masahisa
Sobue, Gen
Zhang, Xiaoping
White, Matthew T.
Sweetser, Marianne T.
Wang, Jing Jing
Ando, Yukio
NEUROLOGY AND CLINICAL NEUROSCIENCE, 2020, 8 (05): : 251 - 260

← 1 2 3 4 5 →